BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 16768640)

  • 21. Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.
    Pavuluri MN; Henry DB; Carbray JA; Naylor MW; Janicak PG
    Bipolar Disord; 2005 Jun; 7(3):266-73. PubMed ID: 15898964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open-label lithium for the treatment of adolescents with bipolar depression.
    Patel NC; Delbello MP; Bryan HS; Adler CM; Kowatch RA; Stanford K; Strakowski SM
    J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):289-297. PubMed ID: 16540813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
    DelBello MP; Adler CM; Whitsel RM; Stanford KE; Strakowski SM
    J Clin Psychiatry; 2007 May; 68(5):789-95. PubMed ID: 17503991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Family conflict moderates response to pharmacological intervention in pediatric bipolar disorder.
    Townsend LD; Demeter CA; Youngstrom E; Drotar D; Findling RL
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):843-52. PubMed ID: 18315455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania.
    Pavuluri MN; Henry DB; Carbray JA; Sampson G; Naylor MW; Janicak PG
    J Affect Disord; 2004 Oct; 82 Suppl 1():S103-11. PubMed ID: 15571784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use.
    Ghaemi SN; Goodwin FK
    J Affect Disord; 2001 Aug; 65(3):281-7. PubMed ID: 11511408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.
    Katila H; Mezhebovsky I; Mulroy A; Berggren L; Eriksson H; Earley W; Datto C
    Am J Geriatr Psychiatry; 2013 Aug; 21(8):769-84. PubMed ID: 23567397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inositol augmentation of lithium or valproate for bipolar depression.
    Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS
    Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment options for bipolar depression: a systematic review of randomized, controlled trials.
    Vieta E; Locklear J; Günther O; Ekman M; Miltenburger C; Chatterton ML; Aström M; Paulsson B
    J Clin Psychopharmacol; 2010 Oct; 30(5):579-90. PubMed ID: 20814319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
    Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
    Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Paulsson B; Mullen J; Vågerö AM
    J Clin Psychopharmacol; 2004 Dec; 24(6):599-606. PubMed ID: 15538120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania.
    Delbello MP; Kowatch RA; Adler CM; Stanford KE; Welge JA; Barzman DH; Nelson E; Strakowski SM
    J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):305-313. PubMed ID: 16540815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.
    Bandelow B; Bauer M; Vieta E; El-Khalili N; Gustafsson U; Earley WR; Eriksson H
    World J Biol Psychiatry; 2014 Feb; 15(2):155-66. PubMed ID: 24506289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.